<DOC>
	<DOCNO>NCT02412904</DOCNO>
	<brief_summary>rFSH HMG use control ovarian stimulation patient submit IVF . However , debate literature one good induce ovulation patient receive GnRH antagonist block premature Luteinizing Hormone ( LH ) secretion . The investigator propose Randomized Clinical Trial ( RCT ) investigate difference among recombinant FSH HMG patient submit IVF use GnRH antagonist .</brief_summary>
	<brief_title>Randomized Controlled Trial Comparing Embryonic Quality rFSH Versus hMG IVF Protocol With GnRH Antagonist</brief_title>
	<detailed_description>To compare embryonic quality clinical outcome use human menopause gonadotropin ( hMG ) recombinant follicle stimulate hormone ( rFSH ) ovarian stimulation IVF cycle GnRH antagonist protocol . Design : open randomize single center study infertile patient submit IVF compare IVF outcome hMG rFSH control GnRH antagonist . Setting : A single private center reproductive medicine association Universidade Federal Rio Grande Sul . Patients : Infertile woman normal ovarian reserve IVF indication . Intervention : The patient randomize two group , 85 receive rFSH 83 receive hMG ovulation induction , group use GnRH antagonist prevent ovulation . Main Outcome Measure : Total embryonic score best embryonic score . Secondary outcome : Total dose gonadotropin , number size follicle end stimulation , number mature oocytes , number embryo , pregnancy rate .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>25 40 infertile submit IVF hormonal disease normal FSH ( &lt; 10 ) antimullerian hormone ( AMH ) &gt; 1 ng &lt; 10 ng ovary first second IVF thyroidstimulating hormone ( TSH ) , prolactin ( PRL ) alter endometrioma ovarian tumor cyst previous Ovarian Hyperstimulation Syndrome ( OHSS ) severe male factor</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>follicular stimulate hormone</keyword>
	<keyword>human menopausal gonadotrophin</keyword>
	<keyword>Recombinant follicular stimulate hormone ( rFSH )</keyword>
	<keyword>Gonadotrophin release hormone ( GnRH ) antagonist</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>vitro fertilization</keyword>
	<keyword>control ovarian stimulation</keyword>
	<keyword>number mature oocyte</keyword>
</DOC>